drugset / Trial / NCT03702530

Immunisation, Treatment and Controlled Human Hookworm Infection

NCT03702530

Completed 23 enrolled Leiden University Medical Center
RandomizedParallel-groupTriple-blindOther

Summary

24 healthy volunteers will be immunized with three times 50 L3 larvae or placebo followed by treatment with albendazol and subsequently challenged with twice 50 L3 larvae.

Timeline

Start
2018-12-17
Primary completion
2019-09-02
Completion
2019-09-02

Drugs

EvaluationDrugModalityDoseRoute
Background Albendazole Small molecule 400 mg

Indications